Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cowen & Co. Upgrades Absci to Outperform

Cowen & Co. Upgrades Absci to Outperform

Cowen & Co. analyst Steven Mah upgrades Absci (NASDAQ:ABSI) from Market Perform to Outperform.

byBenzinga Newsdesk

August 12, 2022

1 minute read

Cowen & Co. analyst Steven Mah upgrades Absci (NASDAQ:ABSI) from Market Perform to Outperform.

News
Tech

Canoo Inks Deal with USPS: Postal Service to Acquire 6 Electric Vehicles

By Anan Ashraf

January 25, 10:46 PM

California-headquartered Canoo Inc. (NASDAQ:GOEV) said on Wednesday that the U.S. Postal Service (USPS) has joined hands with the…

GOEV

Media
News

Disney Shanghai’s Secret Attraction Revealed: Will It Transform Theme Parks?

By Anusuya Lahiri

December 20, 4:17 PM

Walt Disney Co's (NYSE: DIS) Shanghai Disney Resort is preparing to open a new

DIS

Could Twitter Be Elon Musk’s ‘Greatest Investment Ever’? Jim Cramer Isn’t Betting Against The ‘Underestimated’ Tesla CEO

By Adam Eckert

December 15, 6:43 PM

In April, Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said he was done selling Tesla shares to help finance his ongoing overhaul at Twitter.</

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket

By Lisa Levin

September 15, 7:55 AM

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.

ADTX

Cowen & Co. Upgrades Absci to Outperform

Related Posts

Canoo Inks Deal with USPS: Postal Service to Acquire 6 Electric Vehicles

Disney Shanghai’s Secret Attraction Revealed: Will It Transform Theme Parks?

Could Twitter Be Elon Musk’s ‘Greatest Investment Ever’? Jim Cramer Isn’t Betting Against The ‘Underestimated’ Tesla CEO

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket